BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 29984663)

  • 1. Prediction of the Omp16 Epitopes for the Development of an Epitope-based Vaccine Against Brucellosis.
    Rezaei M; Rabbani-Khorasgani M; Zarkesh-Esfahani SH; Emamzadeh R; Abtahi H
    Infect Disord Drug Targets; 2019; 19(1):36-45. PubMed ID: 29984663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches.
    Saadi M; Karkhah A; Nouri HR
    Infect Genet Evol; 2017 Jul; 51():227-234. PubMed ID: 28411163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.
    Tabynov K; Sansyzbay A; Kydyrbayev Z; Yespembetov B; Ryskeldinova S; Zinina N; Assanzhanova N; Sultankulova K; Sandybayev N; Khairullin B; Kuznetsova I; Ferko B; Egorov A
    Virol J; 2014 Apr; 11():69. PubMed ID: 24716528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a new multi-epitope vaccine against
    Chen Z; Zhu Y; Sha T; Li Z; Li Y; Zhang F; Ding J
    Epidemiol Infect; 2021 May; 149():e136. PubMed ID: 34032200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoinformatics prediction of OMP2b and BCSP31 for designing multi-epitope vaccine against Brucella.
    Li Z; Zhang F; Zhang C; Wang C; Lu P; Zhao X; Hao L; Ding J
    Mol Immunol; 2019 Oct; 114():651-660. PubMed ID: 31557626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.
    Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
    Infect Genet Evol; 2017 Nov; 55():151-158. PubMed ID: 28919551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis.
    Pasquevich KA; García Samartino C; Coria LM; Estein SM; Zwerdling A; Ibañez AE; Barrionuevo P; Oliveira FS; Carvalho NB; Borkowski J; Oliveira SC; Warzecha H; Giambartolomei GH; Cassataro J
    J Immunol; 2010 May; 184(9):5200-12. PubMed ID: 20351187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Cross-Protective Potential Antigens against Pathogenic
    Hisham Y; Ashhab Y
    J Immunol Res; 2018; 2018():1474517. PubMed ID: 30622973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel recombinant multi-epitope protein against Brucella melitensis infection.
    Yin D; Li L; Song D; Liu Y; Ju W; Song X; Wang J; Pang B; Xu K; Li J
    Immunol Lett; 2016 Jul; 175():1-7. PubMed ID: 27133932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brucellosis: Improved Diagnostics and Vaccine Insights from Synthetic Glycans.
    Bundle DR; McGiven J
    Acc Chem Res; 2017 Dec; 50(12):2958-2967. PubMed ID: 29219305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-epitope subunit vaccine based on CU/ZN-SOD, OMP31 and BP26 against Brucella melitensis infection in BALB/C mice.
    Wang Y; Wu A; Xu Z; Zhang H; Li H; Fu S; Liu Y; Cui L; Miao Y; Wang Y; Zhumanov K; Xu Y; Sheng J; Yi J; Chen C
    Int Immunopharmacol; 2024 Jan; 127():111351. PubMed ID: 38113688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice.
    Golshani M; Rafati S; Dashti A; Gholami E; Siadat SD; Oloomi M; Jafari A; Bouzari S
    Mol Immunol; 2015 Jun; 65(2):287-92. PubMed ID: 25723468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis of Omp19 and Omp25 proteins for designing multi-epitope vaccines against Brucella.
    Shi D; Chen Y; Chen M; Zhou T; Xu F; Zhang C; Wang C; Li Z
    Medicine (Baltimore); 2023 Mar; 102(11):e33182. PubMed ID: 36930131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
    PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope-Based Vaccine of a
    Oliveira KC; Brancaglion GA; Santos NCM; Araújo LP; Novaes E; Santos RL; Oliveira SC; Corsetti PP; de Almeida LA
    Front Immunol; 2021; 12():778475. PubMed ID: 34992597
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel recombinant multiepitope protein candidate for the diagnosis of brucellosis: A pilot study.
    Yin D; Bai Q; Zhang J; Xu K; Li J
    J Microbiol Methods; 2020 Jul; 174():105964. PubMed ID: 32479870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenic and protective antigens of Brucella as vaccine candidates.
    Masjedian Jezi F; Razavi S; Mirnejad R; Zamani K
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():29-36. PubMed ID: 31300122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella Suis 1300.
    Jalal K; Khan K; Uddin R
    Immunol Res; 2023 Apr; 71(2):247-266. PubMed ID: 36459272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.